Available Technologies   //   Inventor Portal

Get Started with the Polsky Center

Featured

UChicago Launches Polsky Deep Tech Ventures to Support Startups Bringing Science, Tech to Market

Read More
See All Podcasts
UChicago Launches Polsky Deep Tech Ventures to Support Startups Bringing Science, Tech to Market
1 / 1
UChicago Launches Polsky Deep Tech Ventures to Support Startups Bringing Science, Tech to Market
Event //

AbbVie, University of Chicago Symposium to Showcase Latest Oncology Research Efforts

The UChicago-AbbVie Research Symposium celebrates another successful year of strategic partnership, showcasing select innovative research efforts in oncology. Taking place Friday, August 19, 2022, the symposium aims to stimulate…
News //

Met With Too Many Late-Stage Diagnoses, Doctors Create Novel Test to Earlier Detect Cancer in Your Saliva

OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier – improving patient outcomes and saving lives. The Chicago-based startup was formed based on a…
News //

3 Novel Disease-Fighting Technologies You Should Know About Ahead of BIO 2022

Researchers at the University of Chicago have developed methods to increase the clinical efficacy of immunotherapies, provide long-lasting immune tolerance for autoimmune or transplantation therapy, and treat breast and ovarian…
News //

Researchers to Know: UChicago Professors Kunle Odunsi and Rama Ranganathan Recognized for Groundbreaking Work

The Illinois Science and Technology Coalition (ISTC) this year has named University of Chicago Professors Kunle Odunsi and Rama Ranganathan as among its 2021 Researchers to Know. "Research activity at…
News //

Multifunctional Nanomedicine Developed Using Novel UChicago Tech Gets FDA Nod to Initiate Clinical Trials

Coordination Pharmaceuticals, Inc. (CPI) recently announced that the FDA has approved the company's Investigational New Drug (IND) application to initiate a first-in-human Phase 1 clinical study of its novel cancer…
News //

Cancer’s Achilles’ Heel? UChicago Startup Secures $7 Million to Develop ‘Game-Changer’ Treatments

Onchilles Pharma recently closed its Series A funding round, bringing in approximately $7 million, including a $500,000 investment from the University of Chicago’s Startup Investment Fund. Cofounded by UChicago Associate…
News //

F3 Platform Biologics Developing Cancer-Preventing Drugs Based on the Work of UChicago Researcher

Amifostine has a long history and today could potentially help prevent the development of approximately 40,000 cancer cases each year - the goal of F3 Platform Biologics. Amifostine has traditionally…
News //

Patent of the Week: A 3D Culture System for Ovarian Cancer Research

Researchers – including Ernst Lengyel, Arthur L. and Lee G. Herbst Professor of Obstetrics and Gynecology at the University of Chicago – have developed a 3D culture system that…
News //

Clarix Imaging Addresses Unmet Needs with Novel Imaging-Based Solution for Surgical Oncology

Clarix Imaging was founded in 2016 as a spin-off company from the University of Chicago – translating decades of research in advanced medical imaging theory and techniques out of professor…
News //

Patent of the Week: Precisely Delivering High Dose Radiation to Multiple Tumor Sites

University of Chicago researchers have developed an algorithm and prototype software package that successfully generates radiation beam angles for more precisely delivering treatment to multiple tumor sites. Stereotactic ablative…
News //

Patent of the Week: A Low Dose, Multi-Drug Cocktail for Breast Cancer Treatment

More than 150,000 breast cancer survivors were living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III, as of January 1, 2019, according to the American…
News //

Patent of the Week: Identifying High-Risk Triple Negative Breast Cancer Patients

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer and has the least favorable prognosis, as there are fewer targeted medicines available. Accounting for about…
Load More Posts

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept